1. Home
  2. XOMA

as of 03-09-2026 2:51pm EST

$27.00
+$1.00
+3.85%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Founded: 1981 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 308.6M IPO Year: N/A
Target Price: $60.60 AVG Volume (30 days): 134.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $18.40 - $39.92 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 76.93% Revenue Growth (next year): 29.28%
P/E Ratio: 29.64 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: